Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic
The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first…
20/08/2019 - 3 minutes
Nabriva Therapeutics
Another Pneumonia Antibiotic is Close to Treating Patients
Nabriva Therapeutics has obtained positive Phase III results for its antibiotic lefamulin and plans to…
23/05/2018 - 2 minutes
World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance
This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of…
13/11/2017 - 3 minutes
Austrian Biotech Scores a Phase III Win in the Fight Against Antibiotic Resistance
The novel antibiotic lefamulin brought home late-stage success to Nabriva by proving itself to be on…
18/09/2017 - 1 minute
David Chiswell: “We are getting close to the best way of making antibodies”
We interviewed David Chiswell, a pioneer in the development of therapeutic antibodies and now the…
18/09/2017 - 4 minutes
Infographic: The Biggest Biotech Company in Each European Country
We had a look into European biotech and created a map with the biggest biotech…
21/02/2017 - 2 minutes
Grüßgott, get to Meet 9 exciting Biotechs from Vienna
Classical music, the Danube, Schnitzel, and apple strüdel - a typical combination of Vienna. The…
12/09/2016 - 6 minutes
What Happened this Week? Human Embryos Back on the Bench, Stem Cells in your Heart and New Antibiotics
Monday: Nabriva Therapeutics launched its $100M IPO on the NASDAQ to develop new antibiotics Tuesday: the Francis…
27/09/2015 - 1 minute
